This topic contains a solution. Click here to go to the answer

Author Question: Health information technology is a challenge for community and public health nurses in the 21st ... (Read 163 times)

abarnes

  • Hero Member
  • *****
  • Posts: 556
Health information technology is a challenge for community and public health nurses in the 21st century. What is a benefit of health information technology for public health?
 
  A) Improved coordination of care
  B) Support for evidence-based care
  C) Elimination of paperwork
  D) Improved tracking of chronic disease management

Question 2

Health information technology is a challenge for community and public health nurses in the 21st century. What is a benefit of health information technology for patient/client care?
 
  A) Expanded access to affordable care
  B) Increased prevention of disease and disability
  C) Earlier detection of infectious disease
  D) Increased availability of health care evaluation measures



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

reversalruiz

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

D

Answer to Question 2

A





 

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library